RESUMO
Caroli's disease is also known as Congenital intrahepatic bile duct dilatation, and previously known as a congenital intrahepatic bile duct cyst; it is characterized by single or multiple intrahepatic cystic dilatations. In this article, we report a case of Caroli's disease (CT size 21.2 × 16.9 × 19.8 cm). Preoperative abdominal ultrasound and enhanced CT were misdiagnosed as biliary cystadenoma or hepatic echinococcosis, and finally diagnosed as Caroli's disease by postoperative histopathological examinations. Most of the disease is single or multiple cystic dilatation of small bile duct. Giant Caroli disease, cystic dilations with diameter >20 cm is very rarely seen in the clinic. The lack of experience of diagnosing giant cystic dilatation makes it difficult to make accurate diagnosis. Therefore, we analyze the causes of imaging misdiagnosis through this case report, and summarize the imaging diagnostic skills of the disease combined with relevant imaging diagnosis experience. The purpose of this study is to deepen the understanding of giant Caroli disease among imaging doctors so as to reduce the misdiagnosis of the disease in the future.
RESUMO
Alkali metal chlorides have been used as molten salts for further preparing crystalline carbon nitride, but the effect of alkali metal types on the properties of crystalline carbon nitride has not been systematically studied. Therefore, in this paper, a series of crystalline carbon nitride samples doped with different alkali metals were successfully prepared using LiCl-KCl, KCl-NaCl, LiCl-KCl-NaCl and LiCl-NaCl as molten salts: LK-HTCN (Li-K co-doping), KN-HCN (K-Na co-doping), LKN-HTCN (Li-K-Na co-doping) and LN-HTCN (Li-Na co-doping). The experimental results show that KN-HCN contains only the heptazine unit structure, while the other samples contain heptazine and triazine unit structures. Meanwhile, the concentration of the cyano group in the KN-HCN sample structure is significantly higher than that of other samples, which may be related to the fact that there is only a heptazine unit in the structure of the KN-HCN sample. In addition, the loading mode of K and Na ions in the KN-HCN structure is favorable for the migration and separation of photogenerated charges. Thanks to these characteristics, KN-HCN showed excellent photocatalytic ammonia production activity. This study can provide theoretical insight for the development of crystallized carbon nitride.
RESUMO
INTRODUCTION: Metastatic prostate cancer (mPCa) is responsible for most prostate cancer (PCa) deaths worldwide. The present study aims to explore the molecular differences between mPCa and PCa. METHODS: The authors downloaded GSE6752, GSE6919, and GSE32269 from the Gene Expression Omnibus and employed integrated analysis to identify differentially expressed genes (DEGs) between mPCa and PCa. Functional and pathway-enrichment analyses were performed, and a protein-protein interaction (PPI) network and modules were constructed. Clinical mPCa specimens were collected to verify the results by performing RT-qPCR. The Cancer Genome Atlas database was used to conduct a survival analysis, and an immunohistochemical assay was performed. The invasion ability of PCa cells was verified by Transwell assay. RESULTS: One-hundred six consistently DEGs were found in mPCa compared with PCa. DEGs significantly enriched the positive regulation of cell proliferation, cell division, and cell adhesion in small cell lung cancer and PCa. Cell division, nucleoplasm, and cell cycle were selected from the PPI network, and the top 10 hub genes were selected. CDC20 and PTTG1 with genetic alterations were significantly associated with poorer disease-free survival. Immunohistochemical assay results showed that the expression levels of CDC20 and PTTG1 in mPCa were higher than those in PCa. The results of the migration assay indicated that CDC20 and PTTG1 could enhance the migration ability of PCa cells. CONCLUSION: The present study revealed that CDC20 and PTTG1 contribute more to migration, progression, and poorer prognoses in mPCa compared with PCa. CDC20 and PTTG1 could represent therapeutic targets in mPCa medical research and clinical studies.
